Literature DB >> 2152568

Immunological and virological surrogate markers in the evaluation of therapies for HIV infection.

F T Valentine1, M A Jacobson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2152568

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

Review 1.  Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.

Authors:  J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

2.  Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes.

Authors:  Said Aboud; Charlotta Nilsson; Katarina Karlén; Mary Marovich; Britta Wahren; Eric Sandström; Hans Gaines; Gunnel Biberfeld; Karina Godoy-Ramirez
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

3.  Immune complex p24 antigen: a new prognostic marker in human immunodeficiency virus infection.

Authors:  T Cabezas; E Quirós; F Garcia; J Hernández-Quero; M C Bernal; M A Martinez; J de la Higuera; G Piédrola; M C Maroto
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.